Vimian Group AB
STO:VIMIAN
Relative Value
The Relative Value of one VIMIAN stock under the Base Case scenario is hidden SEK. Compared to the current market price of 26.62 SEK, Vimian Group AB is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
VIMIAN Competitors Multiples
Vimian Group AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
V
|
Vimian Group AB
STO:VIMIAN
|
14B SEK | 3.2 | 42.3 | 25.7 | 25.7 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
60B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.1 | 37 | 26.7 | 32.1 | |
| CH |
|
Alcon AG
SIX:ALC
|
30B CHF | 3.8 | 37.4 | 15.5 | 30.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
109.1B DKK | 3.8 | 26.8 | 14 | 16.7 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 3.4 | 35.5 | 16.1 | 20.5 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.7 | 29.5 | 13.1 | 21.3 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.7B CNY | 9.4 | 25.9 | 23.4 | 23.4 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD | 1.2 | -19.7 | 19.6 | 92.4 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4B CHF | 5.1 | 20.9 | 13.6 | 18.4 | |
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.8B USD | 3.2 | 40.4 | 18.4 | 30.7 |